$38.99
+0 (+0%)
At Close: May 26, 2023
Vera Therapeutics Announces Closing of Upsized Public Offering of Class A Common Stock and Full Exercise of Underwriters'' Option to Purchase Additional Shares
09:01pm, Monday, 14'th Feb 2022 Benzinga
BRISBANE, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. ("Vera"), a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the closing of its public offering of 5,742,026 shares of its Class A common stock at a price to the public of $15.00 per share, which includes the full exercise of the underwriters'' option to purchase up to 748,959 additional shares. The gross proceeds to Vera from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses, are approximately $86.1 million. All of the shares were sold by Vera. J.P. Morgan, Cowen, and Evercore ISI acted as joint book-running managers for the offering. Registration statements relating to these securities have been filed with the U.S. Securities and Exchange Commission (SEC) and became effective on February 9, 2022 and February 10, 2022. Copies of these Full story available on Benzinga.
HubSpot jumps on Q4 results, Cowen upgrade; firm sees ''compelling buying opportunity''
12:26pm, Friday, 11'th Feb 2022 Seeking Alpha
HubSpot (HUBS) shares popped in premarket trading after the marketing software firm posted better-than-expected results and guidance, prompting investment firm Cowen to upgrade…
Disney, Roblox, and Affirm are today''s stock picks: Pro Market Movers Feb. 10
09:56pm, Thursday, 10'th Feb 2022 CNBC
Doug Creutz of Cowen, Tom Rogers of Engine Media, Bryn Talkington of Requisite Capital Management, Shannon Saccocia of Boston Private, Rob Sechan of NewEdge Capital Group, Jim Lebenthal of Cerity, and David Wagner of Aptus Capital Advisors explain why they are buying, selling, or holding specific stocks and ETFs.
Moelis (MC) Q4 Earnings and Revenues Lag Estimates
12:05am, Thursday, 10'th Feb 2022 Zacks Investment Research
Moelis (MC) delivered earnings and revenue surprises of -4.05% and 2.68%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Cowen Group (COWN) to Report a Decline in Earnings: What to Look Out for
08:01pm, Wednesday, 09'th Feb 2022 Zacks Investment Research
Cowen (COWN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Despegar Stock Flew 21% Higher in January
03:56pm, Monday, 07'th Feb 2022 The Motley Fool
The Latin American travel website is expected to book big gains in 2022.
4 Top-Ranked Stocks With Impressive Net Profit Margins
01:48pm, Monday, 07'th Feb 2022 Zacks Investment Research
Let's take a look at four Buy-ranked stocks - Euroseas (ESEA), DLH Holdings (DLHC), Franklin Covey (FC) and Cowen Group (COWN) - with solid net profit margins.
Why Despegar Stock Flew 21% Higher in January
10:56am, Monday, 07'th Feb 2022
The Latin American travel website is expected to book big gains in 2022.
4 Top-Ranked Stocks With Impressive Net Profit Margins
10:03am, Monday, 07'th Feb 2022
Let's take a look at four Buy-ranked stocks - Euroseas (ESEA), DLH Holdings (DLHC), Franklin Covey (FC) and Cowen Group (COWN) - with solid net profit margins.
Best Value Stocks to Buy for February 4th
03:12pm, Friday, 04'th Feb 2022 Zacks Investment Research
COWN, COMM, and UMC made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 4, 2022
Best Value Stocks to Buy for February 4th
11:29am, Friday, 04'th Feb 2022
COWN, COMM, and UMC made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 4, 2022
Tradeweb Markets (TW) Q4 Earnings Match Estimates
01:45pm, Thursday, 03'rd Feb 2022 Zacks Investment Research
Tradeweb (TW) delivered earnings and revenue surprises of 0% and 0.34%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Steven Mah, Ph.D., Joins Cowen’s Equity Research Team to Cover Life Science & Diagnostic Tools
12:45pm, Thursday, 03'rd Feb 2022 GlobeNewswire Inc.
NEW YORK, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Cowen Inc. (NASDAQ:COWN) (“Cowen” or the “Company”) today announced that Steven Mah, Ph.D., has joined the Company’s equity research team to fur
Cowen Fixed Income Outsourced Trading Continues Team Expansion With Appointment of John Orrock as Managing Director
08:15am, Wednesday, 02'nd Feb 2022 GlobeNewswire Inc.
LONDON and NEW YORK, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Cowen (NASDAQ:COWN) (“Cowen” or the “Company”) today announced the expansion of its Fixed Income Outsourced Trading team with the appoi
Cowen Named “Best ESG Research” By ESG Investing Magazine
11:00am, Tuesday, 01'st Feb 2022 GlobeNewswire Inc.
NEW YORK, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Cowen Inc. (NASDAQ:COWN) (“Cowen” or the “Company”) today announced that it has been named winner of “Best ESG Research” at the ESG Investing
Sign In
Buy COWN